3D Printed Drugs Market is expected to grow at a CAGR of 15.67% through 2031
Increasing demand for instant soluble drugs is expected to drive the growth of the Global 3D Printed Drugs Market in the forecast period, 2027-2031.
According to TechSci Research report, “3D Printed Drugs Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031”,
the Global 3D Printed Drugs Market will grow from USD 268.89 Million in 2025 to USD 644.02 Million by 2031 at a 15.67% CAGR.
This can be ascribed to the increasing technological innovations in 3D
printing procedures. Additionally, various benefits such as instant solubility
of the drug in the mouth and low cost of manufacturing associated with 3D
printed drugs is expected to support the market growth in the coming years.
Besides, an increasing number of patients suffering from various diseases such
as epilepsy, dysphagia, cancer, etc, is further expected to support the market
growth.
However, usage
of 3D printing to develop illegal drugs and lack of government regulations for
33D printed products may hamper the growth of the global 3D printed drugs market. Additionally, the high cost of modern devices and the unavailability of skilled medical workers may further restrict the growth of the global 3d printed drugs market during the forecast period.
Browse over XX market data Figures
spread through 110
Pages and an in-depth TOC on "3D Printed Drugs Market"
The global 3d printed
drugs market can be
segmented by technology, by application, by end user and by region.
Based on technology, the global 3d printed drugs market can be segmented into inkjet printing, fused deposition modelling, stereolithography, ZipDose technology, and others. The inkjet printing segment dominated the market in 2021
and is expected to continue maintaining its dominance over the next few years
on account of its technological superiority over other techniques. Based on application, the global 3D printed drugs market can be fragmented into orthopaedic, neurology, dental, and other applications. The neurology segment is expected to
dominate the market in the forecast period on account of the growing prevalence
of different neurological disorders such as epilepsy, Parkinson’s disease, etc.
Based on end user, the global 3d printed
drugs market can be segmented into hospitals &
clinics, academic & research institutions, and others. The hospitals & clinics segment dominated the market in 2021 and is expected to continue its dominance over the forecast period on account of the growing prevalence of different diseases along with the rising demand and adoption of precision medicine.
Major companies operating in global 3d printed drugs market are:
- Aprecia Pharmaceuticals, LLC
- FabRx Ltd.
- Merck & Co. Inc.
- Triastek, Inc.
- GlaxoSmithKline plc.
- Formac Pharmaceuticals N.V.
- AstraZeneca plc
- Extend Biosciences, Inc.
- Affinity Therapeutics, LLC
- Osmotica Pharmaceuticals Corporation
Various companies operating in the market are following strategies such as mergers & acquisitions, collaborations, and new product launches in order to stay competitive and having an edge over other players operating in the industry. For instance, in March 2022, CurfiyLabs and Natural Machines collaborated on the manufacturing of 3D printed drugs as per patients’ customized needs.
Download Free Sample Report
Customers can also request a 10% free customisation on this report.
North America is expected to dominate the global 3d printed drugs market due to the increasing incidence of chronic diseases. Besides,
increasing research & development activities in the region for the
development of different 3D printed drugs is further expected to create
lucrative opportunities for the market growth. Additionally, the presence of key market players in the region, especially in the United States, is further expected to support the market growth,” said Mr Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“3D Printed Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others), By Application (Orthopedic, Neurology, Dental, Others), By End User (Hospitals & Clincs, Academic & Research Institutions, Others), By Region 2021-2031F”, has evaluated
the future growth potential of global 3D Printed drugs market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also identifies and analyses the emerging trends along with essential drivers, challenges, and opportunities in the global 3D printed drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com